Synthesis and in vitro antitumor and antimicrobial activity of some 2,3-diaryl-7-methyl-4,5,6,7-tetrahydroindazole and 3,3a,4,5,6,7-hexahydroindazole derivatives

References

• Cerecetto H, Gerpe A, González M, Arán VJ, de Ocáriz CO. Pharmacological properties of indazole derivatives: recent developments. Mini Rev Med Chem 2005;5:869–878.
   PubMed Web of Science ®Google Scholar
• De Angelis M, Stossi F, Carlson KA, Katzenellenbogen BS, Katzenellenbogen JA. Indazole estrogens: highly selective ligands for the estrogen receptor beta. J Med Chem 2005;48:1132–1144.
   PubMedGoogle Scholar
• Zhang HC, Derian CK, McComsey DF, White KB, Ye H, Hecker LR et al. Novel indolylindazolylmaleimides as inhibitors of protein kinase C-beta: synthesis, biological activity, and cardiovascular safety. J Med Chem 2005;48:1725–1728.
   PubMed Web of Science ®Google Scholar
• May JA, Dantanarayana AP, Zinke PW, McLaughlin MA, Sharif NA. 1-((S)-2-aminopropyl)-1H-indazol-6-ol: a potent peripherally acting 5-HT2 receptor agonist with ocular hypotensive activity. J Med Chem 2006;49:318–328.
   PubMed Web of Science ®Google Scholar
• Han W, Pelletier JC, Hodge CN. Tricyclic ureas: a new class of HIV-1 protease inhibitors. Bioorg Med Chem Lett 1998;8:3615–3620.
   PubMed Web of Science ®Google Scholar
• Showalter HD, Angelo MM, Berman EM, Kanter GD, Ortwine DF, Ross-Kesten SG et al. Benzothiopyranoindazoles, a new class of chromophore modified anthracenedione anticancer agents. Synthesis and activity against murine leukemias. J Med Chem 1988;31:1527–1539.
   PubMed Web of Science ®Google Scholar
• Gugliemotti A, Capezzone de Joannon A, Cazzolla N, Marchetti M, Soldo L, Cavallo G, Pinza M. Radical scavenger activity of bendazac, an anticataract non-steroidal antiinflammatory agent. Pharmacol Res 1995; 32:369–373.
   PubMedGoogle Scholar
• Makino R, Obayashi E, Homma N, Shiro Y, Hori H. YC-1 facilitates release of the proximal His residue in the NO and CO complexes of soluble guanylate cyclase. J Biol Chem 2003;278:11130–11137.
   PubMedGoogle Scholar
• Claramunt RM, López C, Pérez-Medina C, Pérez-Torralba M, Elguero J, Escames G et al. Fluorinated indazoles as novel selective inhibitors of nitric oxide synthase (NOS): synthesis and biological evaluation. Bioorg Med Chem 2009;17:6180–6187.
   PubMedGoogle Scholar
• Elguero J, Alkorta I, Claramunt RM, López C, Sanz D, María DS. Theoretical calculations of a model of NOS indazole inhibitors: interaction of aromatic compounds with Zn-porphyrins. Bioorg Med Chem 2009;17:8027–8031.
   PubMedGoogle Scholar
• Ravagnan L, Marzo I, Costantini P, Susin SA, Zamzami N, Petit PX et al. Lonidamine triggers apoptosis via a direct, Bcl-2-inhibited effect on the mitochondrial permeability transition pore. Oncogene 1999;18:2537–2546.
   PubMed Web of Science ®Google Scholar
• Souers AJ, Gao J, Brune M, Bush E, Wodka D, Vasudevan A et al. Identification of 2-(4-benzyloxyphenyl)-N- [1-(2-pyrrolidin-1-yl-ethyl)-1H-indazol-6-yl]acetamide, an orally efficacious melanin-concentrating hormone receptor 1 antagonist for the treatment of obesity. J Med Chem 2005;48:1318–1321.
   PubMed Web of Science ®Google Scholar
• Xia M, Zhang T, Wang Y, Xing G. Preparation of tetrahydroindole and tetrahydroindazole derivatives as anticancer agents (PRC). 2006; WO: 2006133634.
   Google Scholar
• Rosati O, Curini M, Marcotullio MC, Macchiarulo A, Perfumi M, Mattioli L et al. Synthesis, docking studies and anti-inflammatory activity of 4,5,6,7-tetrahydro-2H-indazole derivatives. Bioorg Med Chem 2007;15:3463–3473.
   PubMed Web of Science ®Google Scholar
• Raikova SV, Shub GM, Golikov AG, Kriven’ko AP. [Antimicrobial activity of new original 2-aryliden-6-furfuryliden cyclohexanones and hexahydroindazoles on their basis]. Antibiot Khimioter 2004;49:21–24.
   PubMedGoogle Scholar
• Raikova SV, Shub GM, Luneva IO, Golikov AG, Bugaev AA, Kriven’ko AP. [Chemotherapeutic effect of 3-(5-nitrofuryl)-7-(5-nitrofurfurylidene)-3,3a,4,5,6,7-hexahydro-2H-indazole in experimental staphylococcal infection]. Antibiot Khimioter 2005;50:18–21.
   PubMedGoogle Scholar
• Nagakura M, Ota T, Shimidzu N, Kawamura K, Eto Y, Wada Y. Syntheses and antiinflammatory actions of 4,5,6,7-tetrahydroindazole-5-carboxylic acids. J Med Chem 1979;22:48–52.
   PubMed Web of Science ®Google Scholar
• Nasr MN, Said SA. Novel 3,3a,4,5,6,7-hexahydroindazole and arylthiazolylpyrazoline derivatives as anti-inflammatory agents. Arch Pharm (Weinheim) 2003;336:551–559.
   PubMed Web of Science ®Google Scholar
• Minu M, Thangadurai A, Wakode SR, Agrawal SS, Narasimhan B. Synthesis, antimicrobial activity and QSAR studies of new 2,3-disubstituted-3,3a,4,5,6,7-hexahydro-2H-indazoles. Bioorg Med Chem Lett 2009;19:2960–2964.
   PubMed Web of Science ®Google Scholar
• Gökhan-Kelekçi N, Simsek OO, Ercan A, Yelekçi K, Sahin ZS, Isik S et al. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors. Bioorg Med Chem 2009;17:6761–6772.
   PubMedGoogle Scholar
• Faidallah HM, Al-Saadi MS, Rostom Sh AF. Synthesis of new coumarin-3-carbonylurea, thiourea analogs and some derived ring systems of possible therapeutic interest. J Saudi Chem Soc 2003; 7:367–372.
   Google Scholar
• Al-Saadi MSM, Rostom Sh AF, Faidallah HM. Synthesis and Biological Evaluation of Some 3-Cyano-4-(1-methyl-1H-pyrrol-2-yl)-6-substituted-2(1H)-pyridinones and Their 2-imino isosters. Alex J Pharm Sci 2005; 19:15–21.
   Google Scholar
• Al-Saadi MSM, Rostom Sh AF, Faidallah HM. In vitro antitumor screening of some polysubstituted pyrazole analogs. Saudi Pharm J 2005; 13:89–96.
   Google Scholar
• Al-Saadi MS, Rostom SA, Faidallah HM. 3-methyl-2-(4-substituted phenyl)-4,5-dihydronaphtho[1,2-c]-pyrazoles: synthesis and in-vitro biological evaluation as antitumour agents. Arch Pharm (Weinheim) 2008;341:181–190.
   PubMed Web of Science ®Google Scholar
• Al-Saadi MS, Faidallah HM, Rostom SA. Synthesis and biological evaluation of some 2,4,5-trisubstituted thiazole derivatives as potential antimicrobial and anticancer agents. Arch Pharm (Weinheim) 2008;341:424–434.
   PubMed Web of Science ®Google Scholar
• Faidallah HM, Al-Saadi MS, Rostom SAF. Synthesis and biological evaluation of certain 2H-pyran-2-ones and some derived 1Hpyridin-2-one aanalogs as antimicrobial agents. Saudi Pharm J 2008; 16:33–42.
   Google Scholar
• Rostom SA, Ashour HM, El Razik HA, El Fattah Ael F, El-Din NN. Azole antimicrobial pharmacophore-based tetrazoles: synthesis and biological evaluation as potential antimicrobial and anticonvulsant agents. Bioorg Med Chem 2009;17:2410–2422.
   PubMed Web of Science ®Google Scholar
• Rostom SA, Ashour HM, Abd El Razik HA. Synthesis and biological evaluation of some novel polysubstituted pyrimidine derivatives as potential antimicrobial and anticancer agents. Arch Pharm (Weinheim) 2009;342:299–310.
   PubMed Web of Science ®Google Scholar
• Rostom SA, Hassan GS, El-Subbagh HI. Synthesis and biological evaluation of some polymethoxylated fused pyridine ring systems as antitumor agents. Arch Pharm (Weinheim) 2009;342:584–590.
   PubMed Web of Science ®Google Scholar
• Rostom SA. Polysubstituted pyrazoles, part 6. Synthesis of some 1-(4-chlorophenyl)-4-hydroxy-1H-pyrazol-3-carbonyl derivatives linked to nitrogenous heterocyclic ring systems as potential antitumor agents. Bioorg Med Chem 2010;18:2767–2776.
   PubMed Web of Science ®Google Scholar
• Grever MR, Schepartz SA, Chabner BA. The National Cancer Institute: cancer drug discovery and development program. Semin Oncol 1992;19:622–638.
   PubMed Web of Science ®Google Scholar
• Boyd MR, Paull KD. Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen. Drug Dev Res 1995; 34:91–109.
   Web of Science ®Google Scholar
• Monks A, Scudiero D, Skehan P, Shoemaker R, Paull K, Vistica D et al. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Natl Cancer Inst 1991;83:757–766.
   PubMed Web of Science ®Google Scholar
• Conte JE, Barriere SL. Manual of antibiotics and infectious disease. 1st ed., Lea and Febiger, USA, 1988: 135–138.
   Google Scholar
• Mamolo MG, Vio L, Banfi E, Predominato M, Fabris C, Asaro F. Synthesis and antimycobacterial activity of some 2-pyridinecarboxyamidrazone derivatives. Farmaco 1992;47:1055–1066.
   PubMedGoogle Scholar
• Hassan SY, Basaif SA, Faidallah HM. Synthesis of novel indan [1,2-c] pyrazole benzenesulfonylureas, thioureas and their cyclized derivatives. Egyptian J Chem 1999; 42:213–220.
   Google Scholar
• Güzel O, Innocenti A, Vullo D, Scozzafava A, Supuran CT. 3-phenyl-1H-indole-5-sulfonamides: structure-based drug design of a promising class of carbonic anhydrase inhibitors. Curr Pharm Des 2010;16:3317–3326.
   PubMed Web of Science ®Google Scholar